Pay in 4 interest-free payments of $6.82 Learn more
Ships within 48 hours · Estimated delivery Sep 2 - Sep 7
In preclinical models, BPC-157 acts primarily via VEGFR2 upregulation, focal adhesion kinase modulation, and localized tissue repair, whereas TB-500 (Thymosin Beta-4) acts as an actin-sequestering protein promoting systemic cell migration and actin polymerization
Grows new vessels BPC-157 switches on blood-vessel-growth signals and calms inflammation
Will I need treatment temporarily, for maintenance or for life
Jul-Sep 2021;9(3):e137
The compound is produced as an LPS-free and endotoxin-free research peptide , making it suitable for controlled in vitro and experimental laboratory studies where endotoxin interference must be minimized
US$ 29.62
US$ 27.95
US$ 28.40
US$ 22.20
US$ 27.96
US$ 29.09
US$ 27.09
US$ 26.84
US$ 20.99
